MDXH

NASDAQ 已收盘

MDxHealth SA

0.44 USD
+0.04-2.86%
盘后 0.46 +1.05%
2026-08-03
市值
$22.70M
市盈率
EPS
-0.65
股息率
52 周区间
0.40 – 5.33
成交量
147.29K
Beta
-501299.68
目标价
2.80
52W 低 0.4052W 高 5.33
价格走势

公司简介

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company’s testing solutions include Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient’s previously biopsied negative tissue; ExoD, a non-invasive urine test to assess risk of having clinically prostate cancer; and Resolve mdx for urinary tract infection that identifies personalized effective antibiotic options a...